Siobhan Fogarty - 03 Feb 2025 Form 3 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Signature
/s/ Siobhan Fogarty
Issuer symbol
TNXP
Transactions as of
03 Feb 2025
Net transactions value
$0
Form type
3
Filing time
18 Feb 2025, 06:00:38 UTC
Next filing
27 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNXP Common Stock, $0.001 par value per share 1 03 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNXP Stock Option 03 Feb 2025 Common Stock 1 $352000000.00 Direct F1
holding TNXP Stock Option 03 Feb 2025 Common Stock 1 $217600000.00 Direct F2
holding TNXP Stock Option 03 Feb 2025 Common Stock 1 $12096000.00 Direct F3
holding TNXP Stock Option 03 Feb 2025 Common Stock 1 $13120000.00 Direct F4
holding TNXP Stock Option 03 Feb 2025 Common Stock 1 $256000.00 Direct F5
holding TNXP Stock Option 03 Feb 2025 Common Stock 1 $492800.00 Direct F6
holding TNXP Stock Option 03 Feb 2025 Common Stock 1 $780800.00 Direct F7
holding TNXP Stock Option 03 Feb 2025 Common Stock 1 $132352.00 Direct F8
holding TNXP Stock Option 03 Feb 2025 Common Stock 4 $14622.00 Direct F9
holding TNXP Stock Option 03 Feb 2025 Common Stock 26 $1177.60 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on March 1, 2017 pursuant to the Issuer's 2017 Stock Incentive Plan. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F2 The option was granted on February 13, 2018 pursuant to the Issuer's 2018 Equity Incentive Plan. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F3 The option was granted on February 26, 2019 pursuant to the 2019 Stock Incentive Plan (the "2019 Plan"). The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F4 The option was granted on May 6, 2019 pursuant to the 2019 Plan. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F5 The option was granted on February 25, 2020 pursuant to the Issuer's 2020 Stock Incentive Plan (the "2020 Plan"). The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F6 The option was granted on May 4, 2020 pursuant to the 2020 Plan. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F7 The option was granted on February 23, 2021, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan ( the "A&R 2020 Plan"). The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F8 The option was granted on February 15, 2022, pursuant to the Issuer's A&R 2020 Plan. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F9 The option was granted on February 23, 2023, pursuant to the Issuer's 2023 Employee Stock Purchase Plan (the "2023 Plan"). The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F10 The option was granted on February 27, 2024, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.